Common Variants of Apolipoprotein E and Cholesteryl Ester Transport Protein Genes in Male Patients With Coronary Heart Disease and Variable Body Mass Index. (February 2015)

• Record Type: Journal Article
• Authors: Kolovou, Genovefa D.; Panagiotakos, Demosthenes B.; Kolovou, Vana; Vasiliadis, Ioannis; Giannakopoulou, Vasiliki; Diakoumakou, Olga; Katsiki, Niki; Mavrogeni, Sophie
• Is Part Of: Angiology. Volume 66:Number 2(2015)
• Page Start: 169
• Page End: 173
• Publication Date: 2015-02
• Subjects: gene polymorphisms -- cholesteryl ester transfer protein -- apolipoprotein E -- lipids -- obesity -- body mass index; Blood-vessels -- Diseases -- Periodicals; Cardiovascular system -- Diseases -- Periodicals; 616.13005
• DOI: 10.1177/0003319713517927
• Languages: English
• ISSNs: 0003-3197

Abstract

Plasma lipids are major risk factors for coronary heart disease (CHD). Cholesteryl ester transfer protein (CETP) and apolipoprotein (apo) E genes are involved in lipoprotein metabolism, thus affecting plasma lipid and lipoproteins levels. Furthermore, such polymorphisms have been associated with susceptibility to CHD and obesity. We evaluated the influence of the gene polymorphisms of CETP TaqIB (B1, B2) and I405V (V, I) and apo E (∊2, ∊3, ∊4) on lipid levels, according to body mass index (BMI) in Greek men with CHD. The TaqIB (B1, B2) polymorphism affected plasma low-density lipoprotein cholesterol levels in overweight men with CHD, whereas the I405V (V, I) polymorphism affected triglyceride concentrations in normal weight men. No correlation was found between BMI and apo E polymorphisms. Large prospective studies are required to investigate the relationships of CETP and apo E polymorphisms with lipids, BMI, and CHD susceptibility.